학술논문

G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers.
Document Type
article
Source
FEBS Letters. 594(24)
Subject
G protein-coupled receptors
GTPases
angiogenesis
cancer
cancer metabolism
immune therapy
inflammation
metastasis
precision medicine
signal transduction
Carcinogenesis
Disease Progression
Heterotrimeric GTP-Binding Proteins
Humans
Neoplasms
Receptors
G-Protein-Coupled
Signal Transduction
Language
Abstract
G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play central roles in a diverse array of cellular processes. As such, dysregulation of GPCRs and their coupled heterotrimeric G proteins can dramatically alter the signalling landscape and functional state of a cell. Consistent with their fundamental physiological functions, GPCRs and their effector heterotrimeric G proteins are implicated in some of the most prevalent human diseases, including a complex disease such as cancer that causes significant morbidity and mortality worldwide. GPCR/G protein-mediated signalling impacts oncogenesis at multiple levels by regulating tumour angiogenesis, immune evasion, metastasis, and drug resistance. Here, we summarize the growing body of research on GPCRs and their effector heterotrimeric G proteins as drivers of cancer initiation and progression, and as emerging antitumoural therapeutic targets.